Discovery and innovation are the lifeblood of Pharmaceutical and Life Sciences companies. The UK market, in particular, serves as a powerhouse for early-stage clinical research, supported by the strength of the Golden Triangle. Further advances in digital and artificial intelligence are accelerating research breakthroughs, allowing companies to drive towards personalised and curative therapies.
In parallel, there is increasing pressure from regulators, payers, health care providers, and patients seeking improved health outcomes, transparency, and real-world evidence. As a result, pharma and life sciences organisations are on a mission to optimise R&D output, increase operational agility and re-organise their portfolios to drive new innovative medicines, as well as deliver sustainable growth in line with growing ESG requirements.
Our multi-disciplinary teams and global reach give us a comprehensive view of market opportunities, and allow us to provide unparalleled support across your organisation. At PwC, we demonstrate commitment and passion to build trust and solve important problems, as we work to improve healthcare for all.
Shining a spotlight on the transformational science and innovation pioneered by UK life sciences companies.
Leader of Industry for Government and Health Industries, PwC United Kingdom
Tel: +44 (0)7841 783022
Strategy& Deals and Valuations Partner, PwC United Kingdom
Tel: +44 (0)7887 573735
